StreetInsider.com News Articles

Form D Sernova Biotherapeutics

Thu, 05 Feb 2026 15:31:00 -0500

si-local-file:///var/storage/secattach/20260205/25954378.html

Form D Sernova Biotherapeutics

Thu, 05 Feb 2026 15:31:00 -0500

si-local-file:///var/storage/secattach/20260205/25954378.html

Form D Sernova Biotherapeutics

Thu, 05 Feb 2026 15:31:00 -0500

si-local-file:///var/storage/secattach/20260205/25954378.html

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Tue, 16 Dec 2025 12:00:00 -0500

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive drugs[1]. Meanwhile, stem cell therapies are restoring natural insulin production in human trials, with some patients achieving insulin independence for over a year[2]. As the healthcare industry pivots from managing symptoms to engineering biological solutions, five companies are positioning themselves at the forefront of this regenerative revolution: Avant Technologies, Inc. (OTCQB: AVAI), Vertex Pharmaceuticals